Andrew Zhu
Physician · Mass General Brigham
Credentials: · ·
History
- Present
- 1982–1987
Surgery
- 1978–1982
Doctor of Medicine
Research
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
New England Journal of Medicine · 2020 · 6,239 citations
Hepatology · 2018 · 3,729 citations
AASLD guidelines for the treatment of hepatocellular carcinoma
Hepatology · 2018 · 3,290 citations
67 papers
62 papers · 5 as a fellow
- LB
55 papers
- JC
54 papers
49 papers
41 papers
36 papers
35 papers
Clinical trials
- 2013–2017
HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)
Principal investigator · Terminated · Phase 4
Massachusetts General Hospital
- 2010–2014
STA-9090 in Patients With Advanced Hepatocellular Cancer
Principal investigator · Completed · Phase 1
Massachusetts General Hospital
- 2009–2012
AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
- 2007–2011
RAD001 in Advanced Hepatocellular Carcinoma
Principal investigator · Completed · Phase 1, Phase 2
Massachusetts General Hospital